New approach to halt deadly brain bleeds in blood thinner patients
NCT ID NCT06096051
Summary
This study tested whether a fixed dose of a drug called 4-factor PCC is safe and effective at stopping brain bleeds in people taking certain blood thinners. It involved 76 adults who had a brain bleed and were taking rivaroxaban or apixaban. Researchers compared a fixed dose to a weight-based dose to see which worked better to control the bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.